Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 7/2012

01-07-2012 | Article

Are enterococci playing a role in postoperative peritonitis in critically ill patients?

Authors: P. Seguin, C. Brianchon, Y. Launey, B. Laviolle, N. Nesseler, P.-Y. Donnio, Y. Malledant

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 7/2012

Login to get access

Abstract

This prospective non-interventional study is aimed at evaluating the role of enterococci in the postoperative course of postoperative peritonitis (POP) and the predictive factors for isolating Enterococcus spp. All adult patients, hospitalized in intensive care, who had POP between September 2006 and February 2010 were analysed. The patients’ baseline clinical characteristics and microbiological and surgical characteristics of the first episode of POP were recorded. The rates of surgical and non-surgical complications and mortality were studied. A total of 139 patients were analysed and Enterococcus spp. were recovered in 61 patients (43%). The presence of enterococci was associated with significantly more intra-abdominal abscesses (26% vs 12%, p = 0.025), but did not affect the rate of reoperation or mortality. Antibiotic use before reoperation was the only independent predictive factor for isolating enterococci (OR = 2.19, CI95%: 1.02–4.70, p < 0.043). Although mortality was not affected by the presence of Enterococcus spp., a higher rate of intra-abdominal abscess was found, suggesting that enterococci play a significant role in postoperative peritonitis, but the need to treat them remains to be determined. Previous antibiotic use before reoperation was a key factor in predicting the subsequent recovery of enterococci.
Literature
1.
go back to reference Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, O’Neill PJ, Chow AW, Dellinger EP, Eachempati SR, Gorbach S, Hilfiker M, May AK, Nathens AB, Sawyer RG, Bartlett JG (2010) Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 50(2):133–164PubMedCrossRef Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, O’Neill PJ, Chow AW, Dellinger EP, Eachempati SR, Gorbach S, Hilfiker M, May AK, Nathens AB, Sawyer RG, Bartlett JG (2010) Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 50(2):133–164PubMedCrossRef
2.
go back to reference Augustin P, Kermarrec N, Muller-Serieys C, Lasocki S, Chosidow D, Marmuse JP, Valin N, Desmonts JM, Montravers P (2010) Risk factors for multidrug resistant bacteria and optimization of empirical antibiotic therapy in postoperative peritonitis. Crit Care 14(1):R20PubMedCrossRef Augustin P, Kermarrec N, Muller-Serieys C, Lasocki S, Chosidow D, Marmuse JP, Valin N, Desmonts JM, Montravers P (2010) Risk factors for multidrug resistant bacteria and optimization of empirical antibiotic therapy in postoperative peritonitis. Crit Care 14(1):R20PubMedCrossRef
3.
go back to reference Roehrborn A, Thomas L, Potreck O, Ebener C, Ohmann C, Goretzki PE, Roher HD (2001) The microbiology of postoperative peritonitis. Clin Infect Dis 33(9):1513–1519PubMedCrossRef Roehrborn A, Thomas L, Potreck O, Ebener C, Ohmann C, Goretzki PE, Roher HD (2001) The microbiology of postoperative peritonitis. Clin Infect Dis 33(9):1513–1519PubMedCrossRef
4.
go back to reference Seguin P, Fedun Y, Laviolle B, Nesseler N, Donnio PY, Malledant Y (2010) Risk factors for multidrug-resistant bacteria in patients with post-operative peritonitis requiring intensive care. J Antimicrob Chemother 65(2):342–346PubMedCrossRef Seguin P, Fedun Y, Laviolle B, Nesseler N, Donnio PY, Malledant Y (2010) Risk factors for multidrug-resistant bacteria in patients with post-operative peritonitis requiring intensive care. J Antimicrob Chemother 65(2):342–346PubMedCrossRef
5.
go back to reference Seguin P, Laviolle B, Chanavaz C, Donnio PY, Gautier-Lerestif AL, Campion JP, Malledant Y (2006) Factors associated with multidrug-resistant bacteria in secondary peritonitis: impact on antibiotic therapy. Clin Microbiol Infect 12(10):980–985PubMedCrossRef Seguin P, Laviolle B, Chanavaz C, Donnio PY, Gautier-Lerestif AL, Campion JP, Malledant Y (2006) Factors associated with multidrug-resistant bacteria in secondary peritonitis: impact on antibiotic therapy. Clin Microbiol Infect 12(10):980–985PubMedCrossRef
6.
go back to reference Dupont H, Carbon C, Carlet J (2000) Monotherapy with a broad-spectrum betalactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: a multicenter randomized controlled trial. The Severe Generalized Peritonitis Study Group. Antimicrob Agents Chemother 44(8):2028–2033PubMedCrossRef Dupont H, Carbon C, Carlet J (2000) Monotherapy with a broad-spectrum betalactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: a multicenter randomized controlled trial. The Severe Generalized Peritonitis Study Group. Antimicrob Agents Chemother 44(8):2028–2033PubMedCrossRef
7.
go back to reference Riché FC, Dray X, Laisne MJ, Mateo J, Raskine L, Sanson-Le Pors MJ, Payen D, Valleur P, Cholley BP (2009) Factors associated with septic shock and mortality in generalized peritonitis: comparison between community-acquired and postoperative peritonitis. Crit Care 13(3):R99PubMedCrossRef Riché FC, Dray X, Laisne MJ, Mateo J, Raskine L, Sanson-Le Pors MJ, Payen D, Valleur P, Cholley BP (2009) Factors associated with septic shock and mortality in generalized peritonitis: comparison between community-acquired and postoperative peritonitis. Crit Care 13(3):R99PubMedCrossRef
8.
go back to reference Burnett RJ, Haverstock DC, Dellinger EP, Reinhart HH, Bohnen JM, Rotstein OD, Vogel SB, Solomkin JS (1995) Definition of the role of enterococcus in intraabdominal infection: analysis of a prospective randomized trial. Surgery 118(4):716–721; discussion 721–713PubMedCrossRef Burnett RJ, Haverstock DC, Dellinger EP, Reinhart HH, Bohnen JM, Rotstein OD, Vogel SB, Solomkin JS (1995) Definition of the role of enterococcus in intraabdominal infection: analysis of a prospective randomized trial. Surgery 118(4):716–721; discussion 721–713PubMedCrossRef
9.
go back to reference Mazuski JE, Sawyer RG, Nathens AB, DiPiro JT, Schein M, Kudsk KA, Yowler C (2002) The Surgical Infection Society guidelines on antimicrobial therapy for intraabdominal infections: evidence for the recommendations. Surg Infect (Larchmt) 3(3):175–233CrossRef Mazuski JE, Sawyer RG, Nathens AB, DiPiro JT, Schein M, Kudsk KA, Yowler C (2002) The Surgical Infection Society guidelines on antimicrobial therapy for intraabdominal infections: evidence for the recommendations. Surg Infect (Larchmt) 3(3):175–233CrossRef
10.
go back to reference Cercenado E, Torroba L, Canton R, Martinez-Martinez L, Chaves F, Garcia-Rodriguez JA, Lopez-Garcia C, Aguilar L, Garcia-Rey C, Garcia-Escribano N, Bouza E (2010) Multicenter study evaluating the role of enterococci in secondary bacterial peritonitis. J Clin Microbiol 48(2):456–459PubMedCrossRef Cercenado E, Torroba L, Canton R, Martinez-Martinez L, Chaves F, Garcia-Rodriguez JA, Lopez-Garcia C, Aguilar L, Garcia-Rey C, Garcia-Escribano N, Bouza E (2010) Multicenter study evaluating the role of enterococci in secondary bacterial peritonitis. J Clin Microbiol 48(2):456–459PubMedCrossRef
11.
go back to reference Sitges-Serra A, Lopez MJ, Girvent M, Almirall S, Sancho JJ (2002) Postoperative enterococcal infection after treatment of complicated intra-abdominal sepsis. Br J Surg 89(3):361–367PubMedCrossRef Sitges-Serra A, Lopez MJ, Girvent M, Almirall S, Sancho JJ (2002) Postoperative enterococcal infection after treatment of complicated intra-abdominal sepsis. Br J Surg 89(3):361–367PubMedCrossRef
12.
go back to reference Sotto A, Lefrant JY, Fabbro-Peray P, Muller L, Tafuri J, Navarro F, Prudhomme M, De La Coussaye JE (2002) Evaluation of antimicrobial therapy management of 120 consecutive patients with secondary peritonitis. J Antimicrob Chemother 50(4):569–576PubMedCrossRef Sotto A, Lefrant JY, Fabbro-Peray P, Muller L, Tafuri J, Navarro F, Prudhomme M, De La Coussaye JE (2002) Evaluation of antimicrobial therapy management of 120 consecutive patients with secondary peritonitis. J Antimicrob Chemother 50(4):569–576PubMedCrossRef
13.
go back to reference Bone RC, Sibbald WJ, Sprung CL (1992) The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 101(6):1481–1483PubMedCrossRef Bone RC, Sibbald WJ, Sprung CL (1992) The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 101(6):1481–1483PubMedCrossRef
14.
go back to reference Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R (1994) The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149(3 Pt 1):818–824PubMed Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R (1994) The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149(3 Pt 1):818–824PubMed
15.
go back to reference Bellomo R, Kellum J, Ronco C (2001) Acute renal failure: time for consensus. Intensive Care Med 27(11):1685–1688PubMedCrossRef Bellomo R, Kellum J, Ronco C (2001) Acute renal failure: time for consensus. Intensive Care Med 27(11):1685–1688PubMedCrossRef
16.
go back to reference Matlow AG, Bohnen JM, Nohr C, Christou N, Meakins J (1989) Pathogenicity of enterococci in a rat model of fecal peritonitis. J Infect Dis 160(1):142–145PubMedCrossRef Matlow AG, Bohnen JM, Nohr C, Christou N, Meakins J (1989) Pathogenicity of enterococci in a rat model of fecal peritonitis. J Infect Dis 160(1):142–145PubMedCrossRef
17.
go back to reference Montravers P, Andremont A, Massias L, Carbon C (1994) Investigation of the potential role of Enterococcus faecalis in the pathophysiology of experimental peritonitis. J Infect Dis 169(4):821–830PubMedCrossRef Montravers P, Andremont A, Massias L, Carbon C (1994) Investigation of the potential role of Enterococcus faecalis in the pathophysiology of experimental peritonitis. J Infect Dis 169(4):821–830PubMedCrossRef
18.
go back to reference Onderdonk AB, Bartlett JG, Louie T, Sullivan-Seigler N, Gorbach SL (1976) Microbial synergy in experimental intra-abdominal abscess. Infect Immun 13(1):22–26PubMed Onderdonk AB, Bartlett JG, Louie T, Sullivan-Seigler N, Gorbach SL (1976) Microbial synergy in experimental intra-abdominal abscess. Infect Immun 13(1):22–26PubMed
19.
go back to reference Weinstein WM, Onderdonk AB, Bartlett JG, Louie TJ, Gorbach SL (1975) Antimicrobial therapy of experimental intraabdominal sepsis. J Infect Dis 132(3):282–286PubMedCrossRef Weinstein WM, Onderdonk AB, Bartlett JG, Louie TJ, Gorbach SL (1975) Antimicrobial therapy of experimental intraabdominal sepsis. J Infect Dis 132(3):282–286PubMedCrossRef
20.
go back to reference Cohn SM, Lipsett PA, Buchman TG, Cheadle WG, Milsom JW, O'Marro S, Yellin AE, Jungerwirth S, Rochefort EV, Haverstock DC, Kowalsky SF (2000) Comparison of intravenous/oral ciprofloxacin plus metronidazole versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections. Ann Surg 232(2):254–262PubMedCrossRef Cohn SM, Lipsett PA, Buchman TG, Cheadle WG, Milsom JW, O'Marro S, Yellin AE, Jungerwirth S, Rochefort EV, Haverstock DC, Kowalsky SF (2000) Comparison of intravenous/oral ciprofloxacin plus metronidazole versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections. Ann Surg 232(2):254–262PubMedCrossRef
21.
go back to reference Ohlin B, Cederberg A, Forssell H, Solhaug JH, Tveit E (1999) Piperacillin/tazobactam compared with cefuroxime/metronidazole in the treatment of intra-abdominal infections. Eur J Surg 165(9):875–884PubMedCrossRef Ohlin B, Cederberg A, Forssell H, Solhaug JH, Tveit E (1999) Piperacillin/tazobactam compared with cefuroxime/metronidazole in the treatment of intra-abdominal infections. Eur J Surg 165(9):875–884PubMedCrossRef
22.
go back to reference Solomkin JS, Yellin AE, Rotstein OD, Christou NV, Dellinger EP, Tellado JM, Malafaia O, Fernandez A, Choe KA, Carides A, Satishchandran V, Teppler H (2003) Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial. Ann Surg 237(2):235–245PubMed Solomkin JS, Yellin AE, Rotstein OD, Christou NV, Dellinger EP, Tellado JM, Malafaia O, Fernandez A, Choe KA, Carides A, Satishchandran V, Teppler H (2003) Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial. Ann Surg 237(2):235–245PubMed
Metadata
Title
Are enterococci playing a role in postoperative peritonitis in critically ill patients?
Authors
P. Seguin
C. Brianchon
Y. Launey
B. Laviolle
N. Nesseler
P.-Y. Donnio
Y. Malledant
Publication date
01-07-2012
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 7/2012
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-011-1467-8

Other articles of this Issue 7/2012

European Journal of Clinical Microbiology & Infectious Diseases 7/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine